Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Common Stock history
Currency unavailable · from the balance sheet
No Common Stock data reported for this period type.
Common Stock vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
VCREVicore Pharma Holding AB | Jun 2026 | SEK 88.04M SEK | — | — | 91.8% |
| Mar 2026 | $3.09M USD | +1.6% | +5.3% | 0.4% | |
| Jun 2026 | $2.18M USD | +3.4% | +16.5% | 0.1% | |
| Mar 2026 | $91K USD | +4.6% | -88.8% | 0.1% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | +3.4% | +5.3% | 0.3% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.